(Q44088417)

29 November 2017

title

Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1. (English)

1 reference

29 November 2017

0 references

1 reference

Xuan Feng

1

1 reference

29 November 2017

Anthony L Petraglia

2

1 reference

29 November 2017

Michael Chen

3

1 reference

29 November 2017

Paul V Byskosh

4

1 reference

29 November 2017

Markus D Boos

5

1 reference

29 November 2017

Anthony T Reder

6

1 reference

29 November 2017

publication date

1 August 2002

1 reference

Journal of Neuroimmunology

29 November 2017

published in

1 reference

29 November 2017

volume

129

1 reference

29 November 2017

issue

1-2

1 reference

29 November 2017

page(s)

205-215

1 reference

cDNA structures and regulation of two interferon-induced human Mx proteins

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Viral infections trigger multiple sclerosis relapses: a prospective seroepidemiological study

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

The Antiviral 2′,5′-Oligoadenylate Synthetase Is Persistently Activated in Type 1 Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Hypothesis: multiple sclerosis is a type I interferon deficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Serine phosphorylation of STATs

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Expression of the tyrosine phosphatase SRC homology 2 domain-containing protein tyrosine phosphatase 1 determines T cell activation threshold and severity of experimental autoimmune encephalomyelitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Mechanisms for regulation of cellular responsiveness to human IFN-beta1a

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Signaling via the T cell antigen receptor induces phosphorylation of Stat1 on serine 727

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Association between HLA B7,DR2 and dysfunction of natural- and antibody- mediated cytotoxicity without connection with the deficient interferon production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Intermittent interferonemia and interferon responses in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

The effect of recombinant alpha 2-interferon on defective natural killer cell activity in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Decreased interferon synthesis and responsiveness to interferon by leukocytes from multiple sclerosis patients given natural alpha interferon.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

A role for natural killer cells in the immunopathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Cloning of an interferon regulatory factor 2 isoform with different regulatory ability

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Specificity of signaling by STAT1 depends on SH2 and C-terminal domains that regulate Ser727 phosphorylation, differentially affecting specific target gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Mx proteins in blood leukocytes for monitoring interferon beta-1b therapy in patients with MS

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Tyrosine phosphorylation of DNA binding proteins by multiple cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

69-kDa and 100-kDa isoforms of interferon-induced (2'-5')oligoadenylate synthetase exhibit differential catalytic parameters.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Expression and function of the protein tyrosine phosphatase SHP-1 in oligodendrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Interferon beta augments suppressor cell function in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Multiple sclerosis: in relapsing patients, immune functions vary with disease activity as assessed by MRI

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Lack of interferon gamma receptor beta chain and the prevention of interferon gamma signaling in TH1 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

In vivo gene expression revealed by cDNA arrays: the pattern in relapsing-remitting multiple sclerosis patients compared with normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

In vivo effects of interferon beta-1a on immunosuppressive cytokines in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Clinical viral infections and multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Analysis of gene expression in mutiple sclerosis lesions using cDNA microarrays

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Isoforms p69 and p100 of 2',5'-oligoadenylate synthetase induced differentially by interferons in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

Stat1 serine phosphorylation occurs independently of tyrosine phosphorylation and requires an activated Jak2 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2802%2900182-0

7 January 2021

10.1016/S0165-5728(02)00182-0

Identifiers

DOI

1 reference

29 November 2017

1 reference